Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

AMA adopts new inclusive policies in policy meeting

The American Medical Association has adopted a handful of new policies to guide its future policy work during its interim meeting, including supporting bans on conversion therapy, inclusive electronic health records, racial pay equity in medicine and medical training related to sexual orientation and gender identity.

Thumbnail

Hospital groups to sue HHS to block price transparency rule

Hospital groups are not happy about a new HHS requirement that will force all hospitals to publicly post their prices for services online. A group of hospital associations plan to launch a lawsuit against the agency just days after it finalized the rule, which will take effect Jan. 1, 2021.

Thumbnail

Medicare FFS improper payment rate falls

The improper payment rate in Medicare fee-for-service (FFS) fell to its lowest rate since 2010, according to CMS. However, there were still an estimated $28.9 billion in improper payments made in 2019, down $7 billion from 2017.

Thumbnail

Officials launch investigation into Google, Ascension data project

HHS is looking into a secret project between Google and Ascension after news reports revealed Google was collecting personal health information, including names and birthdates, of millions of U.S. patients under the partnership.

Thumbnail

Providers spend $2.76B annually maintaining directories

Keeping up with accurate provider directories detailing in-network providers comes with a big annual price tag––nearly $3 billion, according to a new report from CAQH.

Thumbnail

Drugmakers could still profit with a $1T loss

Drugmakers are the most profitable industry in the world and would be able to remain profitable after experiencing a $1 trillion loss, according to a report from West Health Policy Center and Johns Hopkins Bloomberg School of Public Health.

Thumbnail

Trump reverses planned ban of flavored e-cigarettes

The Trump administration is walking back on its plan to ban flavored e-cigarettes amidst an epidemic of lung illnesses and deaths related to vaping.

Thumbnail

Google canceled release of 100K images after NIH intervention

Just two days before Google was set to release an expansive set of human chest X-ray images, the National Institutes of Health (NIH) called the tech giant to call it off over privacy concerns, the Washington Post reported. Personal information about the patients in the images were still contained in some of the files and could be used to identify patients, NIH told Google.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.